Small-cap earnings season begins, but the dog days of summer make for dull trading action.
This is still a tricky trading market with many small-caps languishing due to a lack of interest.
As legislation that would let pot stocks list on Nasdaq fails to take root, I'm cultivating other opportunities.
I'm becoming more confident that small-caps have bottomed heading into earnings.
Several names I like are slow fading due to disinterest in small-caps.
One group acting better is the MSO (multi-state operator) pot names.
Just because the volume is lighter, it doesn't make the gains any less real.
Viridian Capital believes Michigan could be the third biggest state for cannabis sales behind California and Colorado.
Traders could maintain longs but raise stop protection.
With a portfolio of 10 names that fit this category, I only need to be correct on one to be profitable. If I hit on more than one, I'm crushing it. And if I hit on three...
The cannabis sector is finally turning back up after a sharp correction that started in early February.
Leading advisors offer their favorite ideas for investors looking for exposure to the growing marijuana market.
The main names that I'm focused on are leveraged to growth in the U.S.
The cannabis biotech company explains why the acquisition of MagicMed makes sense, additional capital raises and the Psybrary.
The charts of the retailer of hydroponic products have improved over the last few months.
I see an opportunity in Hydrofarm Holdings.
Let's check out the charts of the hydroponics supplier.
It's not the multistate operators, but the single-state ones that are where the cool kids are hanging out.
However, a key chart of the producer of beer, wine and spirits indicates the strength of the uptrend could be weakening.
The best momentum on my screens right now are the U.S. cannabis plays that are referred to as Multi-State Operators.
Many believe that cannabis could eventually be treated much the same as tobacco or alcohol.
The data estimates that the U.S. cannabis market will reach $28 billion in sales by 2022.
I'm a put seller of VFF here.
No one likes seeing a name they hold decline in value.
Stay focused on sectors and rotational action if you want to navigate the action.
This market is not nearly as strong as it looks.
There is some very ugly action under the surface.
Charts look vulnerable for the cannabis name as earnings disappoint.
A look at STZ after its latest earnings report.
I'm currently heavily invested in several stocks that are drifting around as I'm quite confident that the eventual catalysts will come.